NRF2 Mutation
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) Trial (NCT04698681) | Calithera Biosciences, Inc | 2021-01-19 |
Track NRF2 Mutation automatically
Every clearance here is in the API, with alerts when new ones post.